Published in Medical Letter on the CDC and FDA, February 29th, 2004
This increase will ensure that the FDA succeeds in meeting the ambitious performance goals negotiated with the medical device industry for prompt review of safe and effective medical devices so that patients can enjoy the benefits of those products sooner. These funds will strengthen the medical device review process and enable FDA to fully apply medical device user fees to the review of medical device...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.